These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24293908)

  • 1. Evaluation of effect and comparision of superoxidised solution (oxum) v/s povidone iodine (betadine): points to ponder.
    Sharma N; Mishra TS; Singh S; Gupta S
    Indian J Surg; 2012 Dec; 74(6):493. PubMed ID: 24293908
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of effect and comparison of superoxidised solution (oxum) v/s povidone iodine (betadine).
    Kapur V; Marwaha AK
    Indian J Surg; 2011 Jan; 73(1):48-53. PubMed ID: 22211038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oxum in treatment of chronic wounds.
    Abhyankar SV; Venkatesh V; Karnad S; Kulkarni KP; Juneja M; Nanda BS; Saifulla T
    J Indian Med Assoc; 2009 Dec; 107(12):904-6. PubMed ID: 20509477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of povidone-iodine on herpesvirus type 2, in vitro.
    Amstey MS; Metcalf S
    Obstet Gynecol; 1975 Nov; 46(5):528-9. PubMed ID: 1196555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of free and bound iodine and iodide species as a function of the dilution of three commercial povidone-iodine formulations and their microbicidal activity.
    Atemnkeng MA; Plaizier-Vercammen J; Schuermans A
    Int J Pharm; 2006 Jul; 317(2):161-6. PubMed ID: 16650702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of the ocular safety of Amukine 0.06% solution for local application versus povidone iodine (Bétadine) 5% solution for ocular irrigation) in preoperative antisepsis].
    Auclin F; Rat P; Tuil E; Boureau-Andrieux C; Morel C; Laplace O; Cambourieu C; Limon S; Nordmann JP; Laroche L; Baudouin C
    J Fr Ophtalmol; 2002 Feb; 25(2):120-5. PubMed ID: 11941231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine.
    Harbison MA; Hammer SM
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):16-20. PubMed ID: 2465403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of free iodine as a function of the dilution of two commercial povidone-iodine formulations.
    Atemnkeng MA; Plaizier-Vercammen JA
    J Pharm Belg; 2006; 61(1):11-3. PubMed ID: 16669342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-linked iodotyrosines in serum after topical application of povidone-iodine (Betadine).
    Alexander NM; Nishimoto M
    J Clin Endocrinol Metab; 1981 Jul; 53(1):105-8. PubMed ID: 6165730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of human immunodeficiency virus by Betadine.
    Kaplan JC; Crawford DC; Durno AG; Schooley RT
    Infect Control; 1987 Oct; 8(10):412-4. PubMed ID: 3667119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization to povidone-iodine.
    van Ketel WG; van den Berg WH
    Dermatol Clin; 1990 Jan; 8(1):107-9. PubMed ID: 2302848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms.
    Van den Broek PJ; Buys LF; Van Furth R
    Antimicrob Agents Chemother; 1982 Oct; 22(4):593-7. PubMed ID: 7181472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical povidone-iodine (Betadine) on serum protein-bound iodine.
    QUAGLIANA JM
    J Clin Endocrinol Metab; 1963 Apr; 23():395-7. PubMed ID: 13972662
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of oxum in treatment of the venous ulcer.
    Dharap SB; Ghag GS; Kulkarni KP; Venkatesh V
    J Indian Med Assoc; 2008 May; 106(5):326, 328-30. PubMed ID: 18839643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECT OF POVIDONE-IODINE (BETADINE) ON SERUM PROTEIN-BOUND IODINE, WHEN USED AS A SURGICAL PREPARATION ON INTACT SKIN.
    HIGGINS HP; HAWKS GH; O'SULLIVAN M; SHAW M
    Can Med Assoc J; 1964 Jun; 90(23):1298-1300. PubMed ID: 14158542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
    Benli E; Cirakoglu A; Ogreden E; Cetinkol Y; Calgin MK; Ayyildiz A; Yüce A
    Adv Urol; 2016; 2016():6841837. PubMed ID: 28096812
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: the CAPICA trial.
    Springel EH; Wang XY; Sarfoh VM; Stetzer BP; Weight SA; Mercer BM
    Am J Obstet Gynecol; 2017 Oct; 217(4):463.e1-463.e8. PubMed ID: 28599898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chemical intravaginal contraceptives and Betadine on Ureaplasma urealyticum.
    Amortegui AJ; Melder RJ; Meyer MP; Singh B
    Contraception; 1984 Aug; 30(2):135-41. PubMed ID: 6548687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative effects of povidone-iodine liquid and gel on the aerobic and anaerobic flora of the female genital tract.
    Monif GR; Thompson JL; Stephens HD; Baer H
    Am J Obstet Gynecol; 1980 Jun; 137(4):432-8. PubMed ID: 7386526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy.
    Daróczy J
    Dermatology; 2006; 212 Suppl 1():82-7. PubMed ID: 16490980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.